From a technical perspective, Delcath Systems, Inc. (NASDAQ:DCTH) bounced notably higher here right off its 50-day moving average of 29 cents per share with decent upside volume. This stock recently formed a major bottom chart pattern, after shares of DCTH found buying interest over the last month at around 28 to 29 cents per share. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.32 in last session, and closed at $0.330, while the day range of DCHT stock is $0.31-$0.34. The stock showed a positive weekly performance of 6.45%.
Generex Biotechnology Corporation (OTCMKTS:GNBT) is a Toronto-based drug delivery system developer with special focus on systems and technology for delivery of diabetes management drugs. The company strives to offer delivery systems on the commercial level, considering the high incidence of diabetes in the recent decades. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04, in last session and closed at $0.0395. The 52 week range was $0.02-$0.06. Company’s market capitalization is $24.48 million.
Valeant Pharmaceuticals Intl (NYSE:VRX) had its price target upped by UBS AG from $141.00 to $170.00 in a research note issued to investors on Friday, AR Network reports. The firm currently has a buy rating on the stock.Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock gained 2.04% and finished the last session at $141.37. The EPS of the stock remained -3.26. Company’s market capitalization is $47.10 billion.
Hospira (NYSE:HSP) was upgraded by analysts at EVA Dimensions from an “underweight” rating to a “hold” rating in a research report issued to clients and investors on Thursday, AnalystRatings.Net reports.Hospira, Inc. (NYSE:HSP) stock opened the session at $43.61, and closed the session at $43.35. The 52 week range of the HSP stock remained $29.63-$45.24 and the day range was $42.98-$43.70.